Encouraging next step in Alzheimer’s research

Alzheimer; News from the web:

AstraZeneca plc (AZNAnalyst Report) and Eli Lilly and Company (LLYAnalyst Report) announced that a phase II/III study (AMARANTH) on their BACE inhibitor, AZD3293, will continue into phase III of the phase II/III seamless study. AZD3293 is being evaluated for the treatment of patients suffering from early Alzheimer’s disease – the most common form of dementia.

Read all about it HERE

Alzheimer’s and Diabetes

Alzheimer; News from the web:

Alzheimer’s disease impairs insulin signalling in the brain, making a person with the most common form of dementia more likely to develop diabetes, suggests a new research conducted in mice.

Read all about it HERE

Crowdfunding R1-OR2-TAT

Alzheimer; News from the web:

That is not a new character in a new Star Wars movie but rather the name of a newly developed, or should I say in development, drug. The researchers however cannot find funding so they turned to crowdfunding the project.

Read all about it HERE